U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
133771133771Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)TerminatedNo Results AvailableExtensive Disease|First-Line|Small Cell Lung CancerDrug: topotecan + cisplatin|Drug: Etoposide + carboplatinhttps://ClinicalTrials.gov/show/NCT00812266
133781133781Parent Mentor Asthma StudyCompletedNo Results AvailableAsthmaBehavioral: Using Parent Mentors to Improve Asthma Care for Urban Minority Childrenhttps://ClinicalTrials.gov/show/NCT00812136
133782133782Calcineurin Free Immunosuppression in Renal Transplant RecipientsCompletedNo Results AvailableKidney Transplantation|Chronic Kidney DiseaseDrug: Sirolimus|Drug: Cyclosporine A|Drug: Prednisone|Drug: Mycophenolate mofetil|Procedure: Protocol biopsieshttps://ClinicalTrials.gov/show/NCT00812123
133783133783Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical HomeCompletedHas ResultsInfluenzaDrug: Influenzae vaccinehttps://ClinicalTrials.gov/show/NCT00812110
133784133784Mentor Siltex® Contour Profile Gel Mammary Prosthesis Clinical TrialCompletedNo Results AvailableBreast Augmentation|Breast Reconstruction|Breast RevisionDevice: Mentor Siltex® Contour Profile Gel Mammary Prosthesishttps://ClinicalTrials.gov/show/NCT00812097
133772133772Intensive Glycemic Control for Congestive Heart Failure ExacerbationCompletedHas ResultsCongestive Heart Failure|Diabetes MellitusDrug: Intravenous insulin|Drug: Subcutaneous insulinhttps://ClinicalTrials.gov/show/NCT00812253
133785133785Costs, Health Status and Outcomes of CAP (Community-Acquired Pneumonia)CompletedNo Results AvailablePneumoniahttps://ClinicalTrials.gov/show/NCT00812084
133773133773A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical TreatmentRecruitingNo Results AvailableGastrointestinal Stromal TumorsDrug: masitinib (AB1010)|Drug: imatinibhttps://ClinicalTrials.gov/show/NCT00812240
133786133786Phase 1B Study of RiVax, a Vaccine to Prevent the Toxic Effects of RicinCompletedNo Results AvailableHealthyBiological: RiVaxhttps://ClinicalTrials.gov/show/NCT00812071
133774133774Neural Correlates of Psychodynamic Psychotherapy for DepressionCompletedNo Results AvailableMajor Depressive DisorderBehavioral: Psychodynamic Psychotherapyhttps://ClinicalTrials.gov/show/NCT00812227
133787133787A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I DepressionCompletedNo Results AvailableBipolar I DepressionDrug: RG2417|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00812058
133775133775Treatment of Insomnia in MigraineursCompletedNo Results AvailableInsomnia|MigraineDrug: eszopiclone|Drug: placebohttps://ClinicalTrials.gov/show/NCT00812214
133788133788Study to Assess Efficacy of AZD1236 in Patients With Cystic FibrosisWithdrawnNo Results AvailableCystic FibrosisDrug: AZD1236|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00812045
133776133776Evaluation of Left Ventricular AutoThresholdCompletedNo Results AvailableHeart FailureDevice: No intervention is used. Collection of signals only.https://ClinicalTrials.gov/show/NCT00812201
133789133789Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic PatientsCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Aspirin|Drug: aspirinhttps://ClinicalTrials.gov/show/NCT00812032
133777133777Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.CompletedNo Results AvailableSymmetric Limited Morphea.Other: Medium Dose UVA-1|Other: High Dose UVA-1https://ClinicalTrials.gov/show/NCT00812188
133790133790Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)CompletedNo Results AvailableInfluenzaBiological: FCC H5N1 3,75 µg|Biological: FCC H5N1 7,5 µg|Biological: FCC H5N1 15 µg|Biological: FCC H5N1 3,75 µg + 25% MF59|Biological: FCC H5N1 7,5 µg + 25% MF59|Biological: FCC H5N1 15 µg + 25% MF59|Biological: FCC H5N1 3,75 µg + 50% MF59|Biological: FCC H5N1 7,5 µg + 50% MF59|Biological: FCC H5N1 15 µg + 50% MF59|Biological: FCC H5N1 3,75 µg + 100% MF59|Biological: FCC H5N1 7,5 µg + 100% MF59|Biological: FCC H5N1 15 µg + 100% MF59https://ClinicalTrials.gov/show/NCT00812019
133778133778Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With SorafenibCompletedNo Results AvailableCarcinoma, HepatocellularDrug: Sorafenib (Nexavar, BAY43-9006)https://ClinicalTrials.gov/show/NCT00812175
133791133791A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine ProphylaxisCompletedHas ResultsMigraineDrug: rizatriptan benzoate|Drug: Comparator: placebohttps://ClinicalTrials.gov/show/NCT00812006
133779133779Effects of Dietary Pork and Egg on Appetite, Meal-patterning, and Weight Loss in MenCompletedNo Results AvailableWeight LossOther: Energy Restriction|Other: Energy Restrictionhttps://ClinicalTrials.gov/show/NCT00812162
133780133780Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3CompletedNo Results AvailableThyroid Disease|Healthyhttps://ClinicalTrials.gov/show/NCT00812149
133792133792A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNo Results AvailableNeoplasmsDrug: RG1507|Drug: RO1507|Drug: bevacizumab [Avastin]|Drug: capecitabine [Xeloda]|Drug: carboplatin|Drug: cetuximab|Drug: docetaxel|Drug: erlotinib [Tarceva]|Drug: etoposide|Drug: gemcitabine|Drug: irinotecan|Drug: mFOLFOX6|Drug: paclitaxel|Drug: pemetrexel|Drug: sorafenib|Drug: temozolomide|Drug: trastuzumab [Herceptin]https://ClinicalTrials.gov/show/NCT00811993
133793133793The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling VentsCompletedNo Results AvailableSepsisDrug: Linezolid or Vancomycinhttps://ClinicalTrials.gov/show/NCT00811980
133794133794Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)TerminatedNo Results AvailableHepatitis C, Chronic|Liver CirrhosisBiological: PegIntron (peginterferon alfa-2b; SCH 54031)|Drug: Rebetol (ribavirin; SCH 18908)https://ClinicalTrials.gov/show/NCT00811967
133795133795Comparative Study of Three NNRTI-Sparing HAART RegimensCompletedHas ResultsHIV InfectionDrug: Emtricitabine/tenofovir disoproxil fumarate|Drug: Raltegravir|Drug: Darunavir|Drug: Ritonavir|Drug: Atazanavirhttps://ClinicalTrials.gov/show/NCT00811954
133796133796Safety and Efficacy of Nalmefene in Patients With Alcohol DependenceCompletedHas ResultsAlcohol DependenceDrug: Placebo|Drug: Nalmefenehttps://ClinicalTrials.gov/show/NCT00811941
133797133797Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)CompletedHas ResultsLeukopeniaDrug: Posaconazole|Drug: Fluconazolehttps://ClinicalTrials.gov/show/NCT00811928
133798133798Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney TransplantationCompletedNo Results AvailableKidney TransplantationDrug: Sirolimushttps://ClinicalTrials.gov/show/NCT00811915
133799133799Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple SclerosisCompletedNo Results AvailableMultiple SclerosisDrug: Nerispirdine (HP184)|Drug: placebohttps://ClinicalTrials.gov/show/NCT00811902
133800133800Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNo Results AvailableChronic Kidney Disease|Type 2 Diabetes|Diabetic NephropathyOther: Placebo|Drug: Bardoxolone Methyl (RTA 402)https://ClinicalTrials.gov/show/NCT00811889

* Görseller ve İçerik tekif hakkına sahip olabilir